Skip to main content
. 2023 Jul 12;5(7):e0946. doi: 10.1097/CCE.0000000000000946

TABLE 2.

Procedural Management

Variables Overall Cohort Propensity-Matched Cohort
Vasopressora (n = 187) No Vasopressor (n = 1,611) p Vasopressora (n = 187) No Vasopressor (n = 187) p
Intubation location < 0.001 0.80
 Emergency department 41 (22%) 575 (36%) 41 (22%) 39 (21%)
 ICU 143 (77%) 1,012 (63%) 143 (77%) 146 (78%)
Operator specialty < 0.001 0.96
 Emergency medicine 45 (24%) 617 (38%) 45 (24%) 46 (25%)
 Critical care 129 (69%) 908 (56%) 129 (69%) 128 (68%)
 Anesthesiology 11 (6%) 60 (4%) 11 (6%) 9 (5%)
 Other 2 (1%) 23 (1%) 2 (1%) 3 (2%)
Operator level of training 0.35 0.10
 Resident/fellow 171 (91%) 1,420 (88%) 171 (91%) 160 (86%)
 Attending physician 9 (5%) 84 (5%) 9 (5%) 10 (5%)
 Advanced practice providerb 7 (4%) 104 (7%) 7 (4%) 17 (9%)
Operator previous intubation experience 50 (30–90) 55 (30–90) 0.88i 50 (30–90) 50 (30–80) 0.54i
Baseline oxygen saturation (%)c 99 (94.5–100) 100 (97–100) 0.004i 99 (94.5–100) 99 (95–100) 0.29i
Pre-induction oxygenation 0.71 0.74
 High-flow nasal cannula 31 (17%) 240 (15%) 31 (17%) 30 (16%)
 Bilevel positive pressure ventilation 44 (24%) 345 (21%) 44 (24%) 50 (27%)
Fio2 prior to intubation 0.50 (0.24–0.90) 0.50 (0.27–0.80) 0.75i 0.50 (0.24–0.80) 0.50 (0.27–0.90) 0.75i
Baseline systolic blood pressure (mm Hg)c 110 ± 24 135 ± 30 < 0.001h 110 ± 24 111 ± 21 0.66h
Vasopressor infusion prior to enrollmentd 103 (55%) 167 (10%) < 0.001 103 (55%) 97 (52%) 0.60
 Norepinephrine 91 (49%) 148 (9%) 91 (49%) 86 (46%)
 Phenylephrine 14 (8%) 20 (1%) 14 (8%) 15 (8%)
 Epinephrine 10 (5%) 16 (1%) 10 (5%) 9 (5%)
 Dopamine 1 (0.5%) 1 (0.1%) 1 (0.5%) 0 (0%)
 Angiotensin II 2 (1%) 2 (0.1%) 2 (1%) 2 (1%)
Induction agents
 Propofol 17 (9%) 106 (7%) 0.22 17 (9%) 17 (9%) > 0.99
 Etomidate 134 (72%) 1,168 (73%) 0.80 134 (72%) 131 (70%) 0.82
 Ketamine 35 (19%) 312 (19%) 0.92 35 (19%) 33 (18%) 0.89
Bag-mask ventilation between induction and intubation 118 (63%) 878 (55%) 0.03 118 (63%) 114 (61%) 0.75
First-attempt successe 157 (84%) 1,346 (84%) > 0.99 157 (84%) 152 (81%) 0.59
Duration of intubation (s)f 130 (96–190) 129 (97–187) 0.79i 130 (96–190) 120 (97–180) 0.40i
Lowest oxygen saturation (%)g 96 (87–100) 97 (88–100) 0.07i 96 (87–100) 96 (89–100) 0.71i
Fluid bolus
 Pre-induction (mL) 63.5 (0–269) 0 (0–250) 0.22i 63.5 (0–269) 0 (0–300) 0.44i
 Total (mL) 125 (0–500) 7.5 (0–450) 0.16i 125 (0–500) 2.5 (0–423) 0.25i
Enrolled in BOUGIE (24) 94 (50%) 935 (58%) 0.05 94 (50%) 95 (51%) > 0.99
Enrolled in PREPARE II (25) 127 (68%) 933 (58%) 0.009 127 (68%) 125 (67%) 0.91

BOUGIE = The Bougie or Stylet in Patients Undergoing Intubation Emergently trial, PREPARE II = Preventing Cardiovascular Collapse With Administration of Fluid Resuscitation During Induction and Intubation trial.

a

Prophylactic administration of vasopressor bolus or dose increase prior to or at induction.

b

Advanced practice providers included physician assistants, certified registered nurse anesthetists, and nurse practitioners.

c

Baseline peripheral arterial oxygen saturation and systolic blood pressure were measured at the time of induction.

d

Any vasopressor or inotropic infusion(s) in the hour prior to enrollment.

e

First-attempt success was defined as a single insertion of a laryngoscope blade into the mouth and passage of endotracheal tube into the trachea.

f

Time from induction to successful endotracheal tube placement in seconds.

g

Lowest peripheral arterial oxygen saturation recorded between induction and 2 min of successful intubation.

h

p value from t test.

i

p value from Wilcoxon rank-sum test.

Values are expressed as mean ± sd, median (interquartile range), and count (%).